Core Points - The Shanghai Composite Index closed at 3993.35 points, remaining above the six-month moving average, with a slight decline of 0.24% [1] - The total trading volume of A-shares reached 1,270.245 billion yuan [1] - A total of 49 A-shares have surpassed the six-month moving average today, with notable stocks showing significant deviation rates [1] Summary by Category Stock Performance - Notable stocks with high deviation rates include: - Qudongli (驱动力) with a deviation rate of 5.91% and a daily increase of 7.05% [1] - Lubridge Information (路桥信息) with a deviation rate of 5.60% and a daily increase of 13.08% [1] - Beiyikang (倍益康) with a deviation rate of 4.75% and a daily increase of 7.60% [1] - Other stocks that just crossed the six-month moving average include: - Qianyuan Pharmaceutical (仟源医药) and *ST Jinke (*ST金科) with smaller deviation rates [1] Trading Activity - The trading turnover rate for Qudongli was 3.59%, while Lubridge Information had a turnover rate of 6.91% [1] - The stock with the highest turnover rate was Aipeng Medical (爱朋医疗) at 19.33% with a daily increase of 10.57% [1] Market Trends - The overall market shows a mix of stocks performing well above the six-month moving average, indicating potential bullish sentiment in certain sectors [1]

Macro Strategy - In October, China's exports showed a year-on-year decline of -1.10%, marking the first negative growth since March 2025, which affected the cumulative year-on-year growth rate, decreasing from 6.10% in September to 5.30% in October. This decline is attributed to a high base in October 2024 and a temporary escalation in trade conflicts between China and the US in early October 2025 [3][4]. Market Overview - From November 3 to November 7, 2025, A-share indices experienced wide fluctuations, with the Shanghai Composite Index rising by 1.08% and the ChiNext Index increasing by 0.65%. The market is expected to continue a "slow bull" trend with wide fluctuations in November due to reduced short-term trade conflict risks between China and the US [4][5]. - Among the 31 first-level industries, the top performers were electric equipment and coal, with weekly increases of 4.98% and 4.52%, respectively. Conversely, the beauty care and computer sectors saw declines of -3.10% and -2.54% [6][7]. North Exchange Market - As of November 7, 2025, the North Exchange had 282 listed stocks, with an average total market value of 908.24 billion yuan, reflecting a 1.24% increase from the previous week. The liquidity decreased, with average trading volume dropping by 17.23% [11][12]. - The highest weekly gain was recorded by Danna Biological, which surged by 377.78% in its first week of trading, while the largest decline was seen in Beiyikang, which fell by 12.35% [13]. Vaccine Industry - The vaccine industry is experiencing structural differentiation, with companies like Kangtai Biological and Zhonghui Biological making significant advancements in vaccine development for specific populations, such as infants and pregnant women. The updated technical guidelines emphasize the importance of vaccination for high-risk groups [17][21]. - The vaccine sector's performance remains under pressure, with a year-to-date decline of -1.57%. The industry is focusing on innovation and international expansion to navigate current challenges [19][21]. - The vaccine sector's price-to-earnings ratio (PE) is currently at 99.07X, reflecting a decrease of 4.97X from the previous week, while the price-to-book ratio (PB) remains stable at 1.94X [20]. Investment Recommendations - The vaccine industry is advised to focus on innovation and international markets, as the current market conditions present challenges due to supply-demand imbalances and intense competition. Companies with strong technological capabilities and differentiated product lines are recommended for investment [21][23].

Market Overview - The small home appliance sector experienced a decline of 0.94% on November 3, with Xiaoxiong Electric leading the drop [1] - The Shanghai Composite Index closed at 3976.52, up 0.55%, while the Shenzhen Component Index closed at 13404.06, up 0.19% [1] Stock Performance - Notable gainers in the small appliance sector included: - ST Dehao: Closed at 2.70, up 5.06% with a trading volume of 266,900 shares and a turnover of 71.53 million yuan [1] - Bi Yi Co., Ltd.: Closed at 20.36, up 3.25% with a trading volume of 47,200 shares and a turnover of 94.92 million yuan [1] - Li Ren Technology: Closed at 29.20, up 2.10% with a trading volume of 19,300 shares and a turnover of 56.44 million yuan [1] - Major decliners included: - Xiaoneng Electric: Closed at 46.25, down 4.05% with a trading volume of 61,600 shares and a turnover of 284 million yuan [2] - Stone Technology: Closed at 156.97, down 3.94% with a trading volume of 88,100 shares and a turnover of 1.379 billion yuan [2] Capital Flow - The small home appliance sector saw a net outflow of 157 million yuan from institutional investors, while retail investors had a net inflow of 205 million yuan [2] - Key stocks with significant capital flow included: - Laike Electric: Net inflow of 8.35 million yuan from institutional investors, but a net outflow of 6.41 million yuan from speculative funds [3] - Xinbao Co., Ltd.: Net inflow of 6.81 million yuan from institutional investors, with a net outflow of 2.90 million yuan from speculative funds [3]

证券代码：920199 证券简称：倍益康 公告编号：2025-115 四川千里倍益康医疗科技股份有限公司 关于召开 2025 年第三次临时股东会通知公告（提供网络投票） 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开基本情况 （一）股东会届次 本次会议为 2025 年第三次临时股东会。 （二）召集人 本次股东会的召集人为董事会。 （三）会议召开的合法合规性 公司于 2025 年 10 月 28 日召开的第四届董事会第三次会议审议通过了《关 于提请召开公司 2025 年第三次临时股东会的议案》，本次股东会的召集及召开时 间、方式、召集人及主持人符合《公司法》《公司章程》及《股东会议事规则》 的规定，审议事项合法、完备。 （四）会议召开方式 本次会议采用现场投票和网络投票相结合方式召开。 公司同一股东只能选择现场投票、网络投票中的一种方式，如果同一表决 权出现重复投票表决的，以第一次投票表决结果为准。 算"）持有人大会网络投票系统对有关议案进行投票表决，为有利于投票意见的 顺利提交，请拟参加网 ...

证券代码：920199 证券简称：倍益康 公告编号：2025-113 四川千里倍益康医疗科技股份有限公司 第四届董事会第三次会议决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开和出席情况 （一）会议召开情况 1.会议召开时间：2025 年 10 月 28 日 2.会议召开地点：公司会议室 3.会议召开方式：现场加通讯 4.发出董事会会议通知的时间和方式：2025 年 10 月 18 日以书面方式发出 5.会议主持人：董事长张文 （二）会议出席情况 会议应出席董事 8 人，出席和授权出席董事 8 人。 二、议案审议情况 （一）审议通过《关于公司<2025 年第三季度报告>的议案》 6.会议列席人员：高级管理人员、董事会秘书 7.召开情况合法合规的说明： 本次会议的召集、召开、议案审议程序等方面符合《公司法》等法律、行政 法规、部门规章、规范性文件和《公司章程》《董事会议事规则》的规定。 1.议案内容： 公司根据 2025 年第三季度的基本情况、财务情况、公司治理及内部控制等 情况，编 ...

东莞证券股份有限公司关于 四川千里倍益康医疗科技股份有限公司变更募集资金 用途的核查意见 东莞证券股份有限公司（以下简称"东莞证券""保荐机构"）作为四川千里倍益 康医疗科技股份有限公司（以下简称"倍益康""公司"）向不特定合格投资者公开发 行的保荐机构，根据《证券发行上市保荐业务管理办法》《北京证券交易所上市公司持 续监管办法（试行）》《北京证券交易所证券发行上市保荐业务管理细则》《北京证券 交易所股票上市规则》等有关法律、行政法规、部门规章及业务细则的要求，对倍益康 变更募集资金用途事项进行了审慎核查，具体情况如下： 一、募集资金基本情况 （一）募集资金金额及募集完成时间 2022 年 11 月 3 日，倍益康发行普通股 11,300,000 股，发行方式为直接定价，发行价 格为31.80元/股，募集资金总额为359,340,000.00元，实际募集资金净额为327,640,820.75 元，到账时间为 2022 年 11 月 24 日。 （二）募集资金使用和存储情况 截至 2025 年 9 月 30 日，公司公开发行募集资金使用情况如下： 单位：万元 | 序号 | 募集资金用途 | 募集资金计划投资总 ...

证券代码：920199 证券简称：倍益康 公告编号：2025-114 四川千里倍益康医疗科技股份有限公司 关于变更募集资金用途的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 （二）募集资金使用情况和存储情况 截至 2025 年 9 月 30 日，公司上述发行股份的募集资金使用情况具体如下： | 序号 | 募集资金用途 | 实施主体 | 募集资金计划 投资总额（调 | 累计投入募 集资金金额 | 投入进度 （%） | | --- | --- | --- | --- | --- | --- | | | | | | | （3）=（2） | | | | | 整后）（1） | （2） | /（1） | | 1 | 成都智能制造生 | 倍益康 | 25,016.71 | 24,953.12 | 99.75% | | | 产基地建设项目 | | | | | | 2 | 研发中心升级建 | 倍益康 | 4,520.50 | 4,358.01 | 96.41% | | | 设项目 | | | | | | 3 | ...

证券代码：920199 证券简称：倍益康 公告编号：2025-111 四川千里倍益康医疗科技股份有限公司 关于全资子公司完成工商变更登记并取得营业执照的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 二、工商变更登记情况 1 三、本次变更对公司的影响 本次公司全资子公司经营范围的变更是基于实际经营发展的需要，有利于全 资子公司业务的开展，变更后不会对公司及全资子公司产生不利影响。 四、备查文件 《东莞市倍益康科技有限公司营业执照》 四川千里倍益康医疗科技股份有限公司 董事会 一、基本情况 四川千里倍益康医疗科技股份有限公司（以下简称"公司"）的全资子公司 东莞市倍益康科技有限公司（以下简称"全资子公司"）因业务发展需要，对其 经营范围进行了变更。目前已完成工商变更登记手续并领取了由东莞市市场监督 管理局换发的《营业执照》。 | 变更 项目 | 变更前 | 变更后 | | --- | --- | --- | | | | 一般项目：技术服务、技术开发、技术咨 | | | | 询、技术交流、技术转让、技 ...